AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 103 filers reported holding AKERO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 4.79 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,800,193 | +134.2% | 35,591 | +77.1% | 0.00% | +33.3% |
| Q1 2023 | $768,682 | -48.1% | 20,091 | -25.7% | 0.00% | -50.0% |
| Q4 2022 | $1,481,573 | +44.3% | 27,036 | -32.1% | 0.01% | -25.0% |
| Q4 2020 | $1,027,000 | +234.5% | 39,815 | +298.7% | 0.01% | +100.0% |
| Q3 2020 | $307,000 | -18.4% | 9,985 | -33.8% | 0.00% | -33.3% |
| Q2 2020 | $376,000 | -8.5% | 15,088 | -22.2% | 0.01% | -45.5% |
| Q1 2020 | $411,000 | -68.4% | 19,398 | -66.8% | 0.01% | +37.5% |
| Q4 2019 | $1,299,000 | +202.8% | 58,508 | +210.0% | 0.01% | +100.0% |
| Q3 2019 | $429,000 | – | 18,874 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 3,271,829 | $125,180,178 | 50.58% |
| COMMODORE CAPITAL LP | 790,000 | $30,225,400 | 4.60% |
| Redmile Group, LLC | 2,044,389 | $78,218,323 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 202,561 | $7,749,984 | 3.20% |
| Ghost Tree Capital, LLC | 275,000 | $10,522,000 | 3.11% |
| Avidity Partners Management LP | 2,447,000 | $93,622,220 | 3.11% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $22,736,043 | 3.08% |
| Logos Global Management LP | 400,000 | $15,304,000 | 2.19% |
| Yiheng Capital Management, L.P. | 1,125,791 | $43,072,764 | 1.70% |
| Boxer Capital, LLC | 831,495 | $31,813 | 1.56% |